小分子プローブによる生物学的理解と治療学的発見の進歩
Stuart L Schreiber1, Joanne D Kotz2, Min Li3
1Probe Development Center, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA; Howard Hughes Medical Institute, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Center for the Science of Therapeutics, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.
Cell
|June 6, 2015
まとめ
生物学と病気の理解に不可欠な小分子探査機は,NIH分子図書館プログラムのおかげで,今よりアクセスしやすくなっています. これらの化学的ツールは,新しい研究分野と薬物の発見を可能にし,継続的なイノベーションの必要性を強調しています.
科学分野:
- 化学生物学 化学生物学とは
- ドラッグ・ディスカバリー・ディスカバリー・ドラッグ・ディスカバリー・ドラッグ・ディスカバリー
- 分子探査機による分子探査機
背景:
- 小分子探査機は,生物学的研究と治療目標の評価に不可欠です.
- 歴史的に見て,利用可能な探査機の欠如は,生物学的経路や病気を調査する際に,その広範な使用を制限しました.
- 国立衛生研究所 (NIH) は,このギャップを埋めるために,2005年に分子図書館プログラムを開始しました.
研究 の 目的:
- NIH Molecular Libraries Programを通じて開発された新しい小分子探査機が,どのように生物学的探査を容易にするかを説明する.
- 新規の治療仮説の検証におけるこれらの探査機の役割を説明する.
- 小分子探査機が生物学研究と医薬品開発の橋渡しに与える影響を強調する.
主な方法:
- この研究は,NIH Molecular Libraries Program (NIH分子図書館プログラム) の影響を分析する視点の作品です.
- 新型の小分子探査機の識別と応用に焦点を当てています.
- 分析は,プログラムの革新によって可能になった経験に基づいています.
主要な成果:
- 新しい小分子探査機は,より広い範囲の生物学的標的と経路のために利用可能になりました.
- これらの探査機は,生物学的プロセスと,以前は検証できなかった治療的仮説の探索を可能にします.
- このプログラムは,小分子科学へのアクセスとイノベーションの幅を広げました.
結論:
- 小分子探査機は,生物学的理解を深め,潜在的な医薬品を特定するための強力なツールです.
- これらの探査機の利用は,基礎研究と治療開発の間のギャップを埋める.
- 治療的発見の科学における継続的なイノベーションは不可欠です.
さらに関連する動画
関連する概念動画
Labeling DNA Probes
9.8K
DNA probes are fragments of DNA labeled with a reporter tag to enable their detection or purification. The resulting labeled DNA probes can then hybridize to target nucleic acid sequences through complementary base-pairing, and may be used to recover or identify these regions.
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...
9.8K
Drug Discovery: Overview
13.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
13.4K
In-situ Hybridization
11.1K
In situ hybridization (ISH) is a technique used to detect and localize specific DNA or RNA molecules in cells, tissue, or tissue sections using a labeled probe. The technique was first used in 1969 for the investigation of nucleic acids. It is currently an essential tool in scientific research and clinical settings, especially for diagnostic purposes.
Types of probes and labels
A probe is a complementary strand of DNA or RNA that binds to corresponding nucleotide sequences in a cell. Many...
Types of probes and labels
A probe is a complementary strand of DNA or RNA that binds to corresponding nucleotide sequences in a cell. Many...
11.1K
DNA Microarrays
23.1K
Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
23.1K
Targets for Drug Action: Overview
11.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
11.9K
Structure-Activity Relationships and Drug Design
2.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
2.1K


